These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19668155)

  • 1. J&J's billion dollar punt on anti-amyloid antibody.
    Sheridan C
    Nat Biotechnol; 2009 Aug; 27(8):679-81. PubMed ID: 19668155
    [No Abstract]   [Full Text] [Related]  

  • 2. Doubts persist for claimed Alzheimer's drug.
    Servick K
    Science; 2019 Dec; 366(6471):1298. PubMed ID: 31831649
    [No Abstract]   [Full Text] [Related]  

  • 3. APOE {epsilon}4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics.
    Kaufer D; Gandy S
    Neurology; 2009 Dec; 73(24):2052-3. PubMed ID: 19923549
    [No Abstract]   [Full Text] [Related]  

  • 4. Failed Alzheimer's trial does not kill leading theory of disease.
    Abbott A; Dolgin E
    Nature; 2016 Nov; 540(7631):15-16. PubMed ID: 27905452
    [No Abstract]   [Full Text] [Related]  

  • 5. GlaxoSmithKline cancer drug threatens Herceptin market.
    Waltz E
    Nat Biotechnol; 2005 Dec; 23(12):1453-4. PubMed ID: 16333273
    [No Abstract]   [Full Text] [Related]  

  • 6. Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease.
    Rabinovici GD; La Joie R
    JAMA; 2023 Aug; 330(6):507-509. PubMed ID: 37459124
    [No Abstract]   [Full Text] [Related]  

  • 7. Deal watch : BMS acquires rights for IL-6 inhibitor.
    Nat Rev Drug Discov; 2010 Jan; 9(1):10. PubMed ID: 20043020
    [No Abstract]   [Full Text] [Related]  

  • 8. PHARMAC responds on Herceptin assumptions and decisions.
    Metcalfe S; Evans J
    N Z Med J; 2007 Aug; 120(1260):U2692. PubMed ID: 17726504
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.
    Panza F; Solfrizzi V; Imbimbo BP; Tortelli R; Santamato A; Logroscino G
    Expert Rev Clin Immunol; 2014 Mar; 10(3):405-19. PubMed ID: 24490853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk-takers wanted.
    Nat Med; 2011 Nov; 17(11):1321. PubMed ID: 22064388
    [No Abstract]   [Full Text] [Related]  

  • 12. Charity's first move is drug investment.
    Mitchell P
    Nat Med; 2002 Apr; 8(4):314. PubMed ID: 11927921
    [No Abstract]   [Full Text] [Related]  

  • 13. Hope for anti-amyloid antibodies surges, yet again.
    Morrison C
    Nat Biotechnol; 2016 Nov; 34(11):1082-1083. PubMed ID: 27824840
    [No Abstract]   [Full Text] [Related]  

  • 14. The socialite scientist.
    Serwer A
    Fortune; 2002 Apr; 145(8):152-4, 158, 160 passim. PubMed ID: 11961885
    [No Abstract]   [Full Text] [Related]  

  • 15. Deal watch: Anti-IL-5 antibody attracts Cephalon to agree option for Ception acquisition.
    Nat Rev Drug Discov; 2009 Mar; 8(3):185. PubMed ID: 19247299
    [No Abstract]   [Full Text] [Related]  

  • 16. Promising drug is victim of bad business.
    Dove A
    Nat Med; 2002 Mar; 8(3):199. PubMed ID: 11875472
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's research. Stopping Alzheimer's before it starts.
    Miller G
    Science; 2012 Aug; 337(6096):790-2. PubMed ID: 22903991
    [No Abstract]   [Full Text] [Related]  

  • 18. Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy.
    Greenberg SM; Frosch MP
    Neurology; 2011 Mar; 76(9):772-3. PubMed ID: 21357829
    [No Abstract]   [Full Text] [Related]  

  • 19. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising Alzheimer's therapies shrink brains.
    Couzin-Frankel J
    Science; 2023 Apr; 380(6640):19. PubMed ID: 37023200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.